Ticker
MNKDCompany Name
MANNKIND CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 57.75M | 0.52 | $ 111.83M |
3/31/2025 | $ 48.05M | 0.41 | $ 115.94M |
12/31/2024 | $ 47.08M | 0.58 | $ 81.84M |
9/30/2024 | $ 63.11M | 0.88 | $ 72.1M |
6/30/2024 | $ 97.38M | 1.22 | $ 80.01M |
3/31/2024 | $ 193.27M | 1.93 | $ 99.9M |
12/31/2023 | $ 238.48M | 2.29 | $ 104.13M |
9/30/2023 | $ 83.02M | 0.86 | $ 96.37M |
6/30/2023 | $ 86.18M | 0.89 | $ 96.97M |
3/31/2023 | $ 85.87M | 1.05 | $ 81.85M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for MANNKIND CORP is calculated as follows: CashnEq [ $ 52.71M ] / LiabilitesC [ $ 106.12M ]
(=) Cash Ratio [ 0.5 ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |